3 Accident & Health Insurance Stocks to Watch Amid Pricing Pressure

The Accident and Health Insurance industry faces persistent pricing pressure due to inflation and rising medical costs, contributing to its underperformance against the broader market year-to-date and a low Zacks Industry Rank (#227). Despite Fitch's prediction of softer performance in 2025, the sector is expected to benefit from increased underwriting exposure, growing demand for supplemental health products, and significant technological adoption, with AI potentially reducing workers' compensation claim expenses by 45%. Companies like Aflac, Trupanion, and Globe Life are positioned to capitalize on these trends through strategic growth initiatives within this evolving market.

Analysis

The Accident and Health Insurance industry presents a mixed outlook, characterized by significant headwinds but also distinct pockets of opportunity. The sector is currently ranked in the bottom 7% of 251 Zacks industries (#227), reflecting a negative aggregate earnings outlook where the 2025 consensus estimate has declined 2.5% over the past year. This weak sentiment is driven by persistent pricing pressure from competition, rising medical costs projected to increase 5.4% annually through 2028, and broader inflation. Consequently, the industry has underperformed, gaining only 4.5% year-to-date compared to the S&P 500's 10.1% rise, and trades at a modest trailing P/B ratio of 1.82X. However, offsetting these challenges are several positive catalysts. Demand for supplemental health products is rising, and the adoption of technology like AI holds the potential to reduce claim expenses by an estimated 45%. Furthermore, while some reports indicate pricing pressure, others project moderate price increases, suggesting a complex environment where prudent underwriting and operational efficiency are paramount. Despite the bleak industry-wide view, specific companies demonstrate strong fundamentals. Trupanion (TRUP) stands out as a high-growth play, with a remarkable 252.2% consensus earnings growth forecast for 2025 in the underpenetrated pet insurance market. Globe Life (GL) and Aflac (AFL) represent more stable opportunities, with Globe Life projecting 15.8% earnings growth in 2025 and Aflac forecasting a 7% earnings increase in 2026 after a projected 2025 dip.

Key Decisions for Investors

• Given the industry's overall underperformance and low Zacks rank, a broad sector-based investment is ill-advised; instead, focus on a stock-picking approach based on individual company fundamentals.
• For growth-oriented portfolios, Trupanion (TRUP) warrants consideration due to its explosive 2025 earnings growth forecast of 252.2% and its position in the large, underpenetrated pet insurance market, though its subsequent 2026 earnings decline projection requires monitoring.
• Investors seeking more stable returns within the sector could consider Globe Life (GL) and Aflac (AFL), which exhibit consistent earnings growth prospects and strategic initiatives, but should remain aware of the overarching industry-wide pricing and margin pressures.
• Closely monitor medical cost inflation and claims frequency data, as these are the primary determinants of underwriting margins and will be critical in assessing whether companies can maintain profitability amid the challenging pricing environment.